Real-time enrollment status for this recurrent acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 12:10 PM UTC
| NCT Number | NCT04140487 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 97 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 13, 2026: Clinical trial NCT04140487 is currently recruiting participants. This clinical trial study for recurrent acute myeloid leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04140487 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04140487 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.